ABOS icon

Acumen Pharmaceuticals

67 hedge funds and large institutions have $148M invested in Acumen Pharmaceuticals in 2023 Q4 according to their latest regulatory filings, with 20 funds opening new positions, 28 increasing their positions, 9 reducing their positions, and 18 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
67
Holders Change
+1
Holders Change %
+1.52%
% of All Funds
0.98%
Holding in Top 10
1
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-50%
% of All Funds
0.01%
New
20
Increased
28
Reduced
9
Closed
18
Calls
$810K
Puts
$4.57M
Net Calls
-$3.76M
Net Calls Change
-$3.56M
Name Holding Trade Value Shares
Change
Shares
Change %
UOC
76
UBS O'Connor
Illinois
-$289K -69,538 Closed
DekaBank Deutsche Girozentrale
77
DekaBank Deutsche Girozentrale
Germany
-$167K -40,000 Closed
Marshall Wace
78
Marshall Wace
United Kingdom
-$106K -25,492 Closed
Verition Fund Management
79
Verition Fund Management
Connecticut
-$97.5K -23,500 Closed
PA
80
Pinnacle Associates
New York
-$74.8K -18,020 Closed
PWMAG
81
Pinnacle Wealth Management Advisory Group
New Jersey
-$74.8K -18,020 Closed
XT
82
XTX Topco
Cayman Islands
-$68.6K -16,538 Closed
CUAMC
83
China Universal Asset Management Company
China
-$6.15K -1,481 Closed
Fidelity Investments
84
Fidelity Investments
Massachusetts
-$2.73K -657 Closed
Daiwa Securities Group
85
Daiwa Securities Group
Japan
-$1K -165 Closed